Australia Stock Exchange release from BCAL DIAGNOSTICS : Change of Director's Interest Notice
02/03/2022 07:32
Australia Stock Exchange release from BCAL DIAGNOSTICS BDX.AX : Change of Director's Interest Notice
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures